CIBC World Market’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-26,864
Closed -$4.48M 988
2019
Q4
$4.48M Buy
+26,864
New +$4M 0.02% 328
2019
Q2
Sell
-25,292
Closed -$3.12M 1117
2019
Q1
$3.12M Sell
25,292
-352
-1% -$44.2K 0.01% 396
2018
Q4
$3M Buy
+25,644
New +$3.02M 0.02% 345
2016
Q1
Sell
-8,071
Closed -$317K 865
2015
Q4
$317K Buy
8,071
+555
+7% +$22.2K ﹤0.01% 737
2015
Q3
$285K Buy
+7,516
New +$317K ﹤0.01% 747
2015
Q1
Sell
-108,893
Closed -$3.2M 813
2014
Q4
$3.2M Buy
108,893
+20,971
+24% +$518K 0.01% 237
2014
Q3
$1.77M Buy
+87,922
New +$1.7M 0.01% 305

Other funds holding AMED

CIBC World Market's AMED Position: Q1 2020 in Review

CIBC World Market sold out of Amedisys (AMED) in Q1 2020, closing a stake of 26,864 shares — an estimated $4.48M sold.

CIBC World Market first reported a position in AMED in Q3 2014 and held it in 7 quarters. The position peaked at $4.48M in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • CIBC World Market reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
  • CIBC World Market sold 26,864 Amedisys shares in Q1 2020, an estimated $4.48M.
  • CIBC World Market first reported a position in Amedisys in Q3 2014 and held it in 7 quarters.
  • CIBC World Market's Amedisys position peaked at $4.48M in Q4 2019.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on CIBC World Market's 13F filing for Q1 2020, filed 15 May 2020.